Patent application number | Description | Published |
20090045715 | MODULAR LIGHTING APPARATUS - A modular lighting apparatus includes a replaceable bulb assembly, an adapter, and a mechanical and electrical connector assembly that removably connects the bulb assembly to the adapter for use. The bulb assembly includes a light-emitting component mounted to a body. In example embodiments the light-emitting component includes spiral-tube CFLs, low-profile transverse CFL tubes, and omni-directional LED arrays. The adapter includes a standard screw base mounted to a body that houses an electronic ballast. In this way, the bulb assembly can be removed from the adapter and replaced, while reusing the electronic ballast in the adapter. And the screw-base adapter allows the reuse of the electronic ballast in standard screw-socket household light fixtures. In addition, the reusable adapter base also may be provided with an integral photocell for light-based control of the lighting apparatus without increasing the overall height of the composite lighting apparatus. | 02-19-2009 |
20090311311 | TRANSDERMAL LOCAL ANESTHETIC PATCH WITH INJECTION PORT - Described herein are transdermal delivery devices composed of at least one re-sealable injection port and at least one local anesthetic reservoir. The device effectively delivers anesthetic to the skin of the subject prior to puncturing the skin by syringes, needle sticks, or other instruments intended to be inserted into the skin. In addition, this device can be used to deliver various therapeutic agents for either locally or systemically. | 12-17-2009 |
20100172865 | METHODS OF ENHANCING HAIR GROWTH - A method of enhancing scalp hair growth utilizes insulin and/or IGF-1 alone or in combination with other known hair growth promoting therapeutic, pharmaceutical and biological agents to increase the therapeutic effects of hair regrowth strategies to enhance hair growth on the scalp and as method of treatment for balding. | 07-08-2010 |
20110020252 | METHOD OF LONG LASTING HUMAN SKIN TANNING - The invention relates to the use of Rifampin and its related compound as a method of producing long-lasting, effective skin tanning for human and animal. The invention relates to methods of accelerating and facilitating the tanning of the skin using Rifampin along with use of the other tanning facilitators and accelerants with or without UVR. | 01-27-2011 |
20110020279 | RABIES CURE - This invention is for a method of treatment of rabies once the patient develops signs and symptoms of rabies with the intent to save the patients from death and disability using insulin combined with various anti rabies viral therapeutic, pharmaceutical, biochemical, and biological agents or compounds with added supportive therapies administered through OM, SAS, IVB, IV, and IA routes. An embodiment provides devices for intranasal delivery of therapeutic agents to olfactory mucosal area. Another embodiment uses the technology to deliver the therapeutic, pharmaceutical, biochemical, and biological agents or compounds to the subarachnoid space and ventricular system by using continuous catheters and Ommaya reservoir at the same time. The present method incorporates breaking the blood brain barrier to allow the entry of the anti rabies therapeutic agents into the neuropile. Additionally, an embodiment incorporates cooling of the brain and inducing hibernation to preserve the brain from damage due to rabies. | 01-27-2011 |
20110021974 | RETINITIS PIGMENTOSA TREATMENT AND PROPHALAXIS - The invention relates to a method of instilling insulin ophthalmic drops in the conjunctival sac for treating retinitis pigmentosa due to any etiological factors both genetic and non genetic. The retinitis pigmentosa is treated with Insulin and/or IGF-I with or without known anti-retinitis pigmentosa therapeutic, pharmaceutical, biochemical, and biological agents or compounds. The invention furthermore uses this method as prophylactic on patients where the patients are predisposed to develop retinitis pigmentosa. The invention additionally treats other oculopathies associated with and/or contributing to retinitis pigmentosa. | 01-27-2011 |
20110052678 | METHOD FOR TREATING AGE RELATED MACULAR DEGENERATION - A method for treating age related macular degeneration uses insulin preparation applied topically in a therapeutically effective amount to an affected conjunctival sac of the eye. The topically effective dose is delivered to the fovea centralis and macula lutea. In other embodiments, additional therapeutic, pharmaceutical, biochemical, nutriceutical, biological (monoclonal antibodies and others) agent or compound, and organic and inorganic agents are also applied to the afflicted site through the conjunctival sac and choroidal vascular system of the eye. IGF-1 may be applied as well with or without insulin to treat ARMD. | 03-03-2011 |
20110080739 | Light with Replaceable Light Source - A light with replaceable light source has a base that fits within a standard light socket. The base has a threaded portion that is adapted to receive a complementary threaded portion in an outer protective bulb. The base holds a plug used to removably attach a sealed inner bulb. There is a plurality of holes in the outer bulb to allow air to flow therein. The sealed inner bulb is replaced as needed. Additionally, the inner sealed bulb may be an incandescent, CFL or LED. In one embodiment, a sensor is provided to provide automatic operation. In another embodiment, three-way functionality is provided. Replacement sealed bulbs may be provided in a bulk pack to further economize. | 04-07-2011 |
20110081333 | APPARATUS AND SYSTEM FOR TREATMENT AND PREVENTION OF BAGS UNDER EYES - A simple, safe and effective invention devices for treating bags under the eyes pressure exerting glasses devices, compress badges, bag pressure adhesive strips, cosmetic pressure adhesive strips; to be put on to prevent, and to reduce the bags under the eyes. They are designed to apply antiwrinkle and other cosmetic and therapeutic agents such as hormones, known therapeutic agents, as well as other pharmaceutical, biochemical, nurticeuticals and biological agents, or compounds to enhance the health and beauty of the eye, strengthen the lower eye lids and to treat many oculopathies which can contribute to the condition. They can be used for the eye makeup cosmetically as adjuvant to eye makeup. The electrical stimulation and electromotive force are incorporated in the invention to strengthen the lower eye lids muscles, to improve the health of the eye lids skin and for the delivery of therapeutic agents to treat various oculopathies. | 04-07-2011 |
20110089725 | LEG SUPPORTING DEVICE FOR USE BEHIND A HEAD REST FOR AIR AND VEHICULAR TRAVEL - A leg supporting device for use behind a head rest for air and vehicular travel has a head rest support portion that fits over a head rest of a forwardly positioned seat and supports a back flap portion that hangs down behind the forwardly positioned seat. A pair of adjustment straps adjustably attach to the back flap portion and supports a foot support portion. A user slips one or both of their feet into the foot support portion and then adjusts the adjustment straps to support their feet at a desired height and position. The foot support portion handles to carry it. In use, the leg supporting device can be folded and placed within the foot support portion and carried using the handles until needed. One embodiment includes pockets for holding drinks, computer, and other carry-on items. A leg massage unit may be built in for additional relief. | 04-21-2011 |
20110166498 | METHODS FOR REDUCING PAIN USING A TRANSDERMAL LOCAL ANESTHETIC PATCH WITH INJECTION PORT IN COMBINATION WITH AN ELECTROMOTIVE FORCE - Described herein are transdermal delivery devices composed of at least one resealable injection port and at least one local anesthetic reservoir. The device effectively delivers anesthetic to the skin of the subject prior to puncturing the skin by syringes, needle sticks, or other instruments intended to be inserted into the skin. In addition, the transdermal delivery device may include a single use patch that does not include a local anesthetic refill port. The devices are used in combination with an electromotive force in order to enhance pain reduction when a subject is injected with a needle. Devices for imparting an electromotive force to a subject are also described herein. | 07-07-2011 |
20110217260 | METHOD OF ENHANCING EYELASH AND EYE BROW HAIR GROWTH - A method of enhancing eyelash and eye brow hair growth utilizes insulin and/or IFG-1 alone or in combination with other known hair growth promoting therapeutic, pharmaceutical, biochemical and biological agents to increase the effect of various therapeutic hair regrowth strategies to enhance eyelash and eye brow hair growth. | 09-08-2011 |
20110294730 | METHOD OF TREATING GLAUCOMA AND INTRAOCULAR HYPERTENSION - A safe and effective treatment for glaucoma for mammalian species comprises the steps of applying insulin and/or insulin like growth factors (IGF-1) to an eye. In addition to the insulin, another therapeutic agent may be applied to enhance the activity of the insulin. The therapeutic agent may be a pharmaceutical agent or a biochemical pharmaceutical agent. The therapeutic agents include prostaglandin analogs, topical beta-adrenergic receptor antagonists-β blockers, Alpha2-adrenergic agonists hair growth therapeutic agents, beta2-agonist action agents, parasympathomimetic miotic agents, carbonic anhydrase inhibitors, and Physostigmine. In another embodiment, a combination of at least two agents are applied to the eye. To enhance the effect of the insulin, uptake facilitators may be used. Additionally, an antibacterial agent may be applied to control bacterial infection. | 12-01-2011 |
20120003296 | NEW METHODS OF TREATING DRY EYE SYNDROME - The invention relates to a method of insulin eye drops for treating dry eye syndrome due to any and all etiological factors (Keratoconjunctivitis sicca), including Sjogren's syndrome, Meibomian gland dysfunction (MGD) and other glandular malfunction in the eye lids, lacrimal glands, cornea, conjunctiva, and exposed scleral surface of the eye. It is treated with Insulin and/or IGF-I with or without known anti-dry eye syndrome therapeutic, pharmaceutical, biochemical and biological agents or compounds. | 01-05-2012 |
20120203141 | METHOD AND APPARATUS FOR REDUCING/SUPPRESSING PAIN IN DIGITS - A therapeutic device and method for blocking pain in a patient's digit includes a ring-like vibratory element adapted to be fitted about the digit temporarily and controller coupled to the ring-like vibratory element for controlling its operation. By applying vibration to the patient's digit, pain transmission is blocked or lessened along the digit, allowing the patient or a caregiver to provide treatment to the digit with reduced pain, such as when a diabetic's finger is to be stuck for drawing blood for a blood sugar measurement). Moreover, if the digit is injured, the present invention can provide pain relief from the injury as well. Further, the invention can be applied to the digit in combination with other pain-reducing therapies, such as the application of ice, the application of topical analgesics, the application of local anesthetics, etc. The controller includes an on/off control switch and a switch for controlling the vibratory frequency. The controller further includes a battery power source for powering the ring-like vibratory element. Also, the ring-like vibratory element includes an electrically-powered vibratory motor and/or a piezoelectric ultrasound transducer for creating vibrations in the digit. The vibratory element includes two vibratory parts, to be positioned on opposite sides of the digit, along the nerve bundles to maximize the blockage of pain. | 08-09-2012 |